In recent years, systemic chemotherapy and molecular targeted therapy have become standard firstline treatments for locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC). | A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB IV nonsquamous non-small cell lung cancer in China CTONG 1506